Prevention

Lower risk of all-cause and cardiovascular mortality observed only among morning drinkers

Recent developments of interest in cardiovascular medicine

But emulated trial found more myocardial infarctions than with bisphosphonate users

Recent developments of interest in cardiovascular medicine

Deeper stories often get lost in a fast-paced news environment

Achieving remission and addressing CV risk factors made a big difference in Greek study

Macitentan/tadalafil and sotatercept approvals shifted the field, but by how much seems to differ

Recent developments of interest in cardiovascular medicine

Large meta-analysis shows conflicting evidence for higher vs lower dosing

Also in TTHealthWatch: electronic nudges for flu shots

Antisense oligonucleotide olezarsen slashes high triglycerides

Previous findings of more cardiac events in RA patients did not translate to IBD patients

Nearly a year added to estimated lifespan of Americans

Biomarker of wine consumption believed to reduce misclassification and bias in study